Quoin Pharmaceuticals Reports Results for Quarter Ended June 30, 2026

What Happened

• On August 14, 2026 Quoin Pharmaceuticals Ltd. filed a Form 8-K (Item 2.02) to announce its financial results for the quarter ended June 30, 2026.
• The company furnished a press release dated August 14, 2026 as Exhibit 99.1 to the 8-K; that press release contains the detailed quarterly results (earnings, revenue and other financial metrics).

Key Details

• Filing date: August 14, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Period covered: quarter ended June 30, 2026.
• Disclosure format: press release furnished as Exhibit 99.1 and incorporated by reference.
• The Form 8-K includes the required cover page interactive XBRL file (Inline XBRL).

Why It Matters

• This 8-K is the company’s formal public disclosure that it reported quarterly financial results; investors should review the attached press release for specific figures on revenue, net income (or loss), cash position, and any commentary on business drivers.
• Quarterly results can affect Quoin’s stock price and investor expectations; retail investors should read the Exhibit 99.1 press release and company investor relations updates for the detailed numbers and any guidance or management commentary.